A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
P. R. Shiroma, P. Thuras, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
M. I. Husain, D. M. Blumberger, et al.
Efficacy of green jackfruit flour as a medical nutrition therapy replacing rice or wheat in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study
A. G. Rao, K. S. Naik, et al.
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
L. Leyl, F. Holze, et al.
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
P. Glue, C. Loo, et al.
